RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 83 filers reported holding RAPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,551,921 | -11.1% | 2,680,621 | 0.0% | 29.58% | +52.1% |
| Q2 2023 | $50,127,613 | +1.9% | 2,680,621 | 0.0% | 19.45% | +9.4% |
| Q1 2023 | $49,189,395 | -7.3% | 2,680,621 | 0.0% | 17.79% | +0.7% |
| Q4 2022 | $53,076,296 | -17.7% | 2,680,621 | +0.0% | 17.67% | +23.8% |
| Q3 2022 | $64,492,000 | +31.8% | 2,680,458 | 0.0% | 14.27% | +37.1% |
| Q2 2022 | $48,918,000 | +58.7% | 2,680,458 | +91.2% | 10.41% | +82.1% |
| Q1 2022 | $30,830,000 | -40.1% | 1,402,008 | 0.0% | 5.72% | -18.4% |
| Q4 2021 | $51,496,000 | +18.3% | 1,402,008 | 0.0% | 7.00% | +41.4% |
| Q3 2021 | $43,532,000 | -64.8% | 1,402,008 | -63.9% | 4.95% | -71.7% |
| Q2 2021 | $123,526,000 | +43.2% | 3,885,679 | 0.0% | 17.48% | +111.5% |
| Q1 2021 | $86,262,000 | +12.4% | 3,885,679 | 0.0% | 8.26% | +18.7% |
| Q4 2020 | $76,742,000 | – | 3,885,679 | – | 6.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $58,747,000 | 54.16% |
| KPCB XV Associates, LLC | 1,297,063 | $47,641,000 | 37.58% |
| Ponoi II Management, LLC | 145,401 | $5,341,000 | 9.70% |
| Euclidean Capital LLC | 432,900 | $15,900,000 | 9.04% |
| Column Group LLC | 1,402,008 | $51,496,000 | 7.00% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,655,000 | 5.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $42,178,000 | 4.85% |
| Ghost Tree Capital, LLC | 350,000 | $12,856,000 | 4.61% |
| Velan Capital Investment Management LP | 110,000 | $4,040,000 | 3.14% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $16,294,000 | 2.28% |